Related Experiment Video

Updated: Aug 9, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.0K

The Emerging Role of m6A Modification in Endocrine Cancer

Xiaoyu Ji1, Zhiyuan Wang1, Wei Sun1

  • 1Department of Thyroid Surgery, The First Hospital of China Medical University, No. 155 Nanjing North Street, Shenyang 110001, China.

Cancers
|February 25, 2023
PubMed

Insights

N6-methyladenosine (m6A) RNA modifications are crucial in cancer research, particularly in endocrine cancers. Understanding m6A alterations offers potential for new diagnostic markers and therapeutic targets in these malignancies.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Oncology

Background:

  • N6-methyladenosine (m6A) is a key internal epigenetic modification in eukaryotic mRNA.
  • m6A regulation involves methylases, demethylases, and m6A-binding proteins, influencing gene expression dynamically.
  • This reversible post-transcriptional modification is increasingly recognized for its role in cancer development, including promoting tumor stem cell self-renewal and proliferation.

Purpose of the Study:

  • To review the recent experimental advancements in m6A modification within endocrine cancers.
  • To highlight the significance of m6A alterations as potential diagnostic markers for endocrine malignancies.
  • To underscore the importance of identifying novel therapeutic targets for improved treatment and prognosis of endocrine cancers.

Main Methods:

  • Literature review of experimental studies on m6A modification in endocrine cancers.
  • Analysis of the role of m6A in tumor progression, stemness, and proliferation.
  • Synthesis of current understanding of m6A regulatory mechanisms in endocrine malignancies.

Main Results:

  • m6A-modified genes represent promising targets for cancer breakthroughs.
  • Endocrine cancers, despite rarity, can exhibit high mortality rates, necessitating focused research.
  • m6A alterations are implicated in the progression and characteristics of endocrine cancers.

Conclusions:

  • m6A modification plays a significant role in the pathogenesis of endocrine cancers.
  • m6A alterations show potential as diagnostic biomarkers for endocrine malignancies.
  • Targeting m6A pathways may offer novel therapeutic strategies for endocrine cancer treatment.
Keywords:
demethylaseendocrine cancerm6Amethyltransferase

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.4K
Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study06:57

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study

Published on: July 7, 2023

1.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K